An analyst estimates HealthEquity (HQY) at US$104, 33% below fair value. Using a DCF model, the intrinsic value is US$14b, suggesting the stock is undervalued at a 47% discount.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing
An analyst estimates HealthEquity (HQY) at US$104, 33% below fair value. Using a DCF model, the intrinsic value is US$14b, suggesting the stock is undervalued at a 47% discount.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing
We are preparing, please wait
This content is only available for premium members. Please become a paid member to access.
Download AppCurrently, memberships can only be purchased through the app.